Prudential PLC Has $24.42 Million Position in Axon Enterprise, Inc $AXON

Prudential PLC grew its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 11.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 34,032 shares of the biotechnology company’s stock after buying an additional 3,400 shares during the period. Prudential PLC’s holdings in Axon Enterprise were worth $24,423,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Vestor Capital LLC boosted its holdings in Axon Enterprise by 438,636.3% in the second quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock valued at $690,170,000 after acquiring an additional 833,409 shares during the last quarter. Norges Bank bought a new position in Axon Enterprise during the 2nd quarter worth approximately $637,806,000. Vanguard Group Inc. raised its holdings in Axon Enterprise by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after purchasing an additional 376,904 shares during the last quarter. Jennison Associates LLC lifted its position in shares of Axon Enterprise by 53.8% in the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after purchasing an additional 330,213 shares during the period. Finally, 1832 Asset Management L.P. lifted its position in shares of Axon Enterprise by 129.2% in the 2nd quarter. 1832 Asset Management L.P. now owns 536,420 shares of the biotechnology company’s stock worth $444,124,000 after purchasing an additional 302,420 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the sale, the chief executive officer owned 3,090,997 shares in the company, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the transaction, the insider owned 55,588 shares in the company, valued at approximately $29,740,135.88. The trade was a 3.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 24,634 shares of company stock worth $13,803,095. 4.40% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on AXON shares. Citigroup reiterated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Needham & Company LLC dropped their target price on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Finally, Craig Hallum reissued a “buy” rating and issued a $820.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $762.93.

Axon Enterprise Trading Down 0.6%

Shares of Axon Enterprise stock opened at $496.18 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The stock has a 50 day moving average price of $531.08 and a two-hundred day moving average price of $610.44. The stock has a market capitalization of $39.89 billion, a PE ratio of 326.44, a price-to-earnings-growth ratio of 10.66 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. During the same period in the prior year, the firm earned $2.08 earnings per share. Axon Enterprise’s revenue for the quarter was up 38.5% on a year-over-year basis. As a group, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.